Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


Profits, supply impacted by cyberattack says MSD

Posted 31 July 2017

The cyberattack which shutdown MSD Australia for almost a week in July has forced the company to globally downgrade profits and warn some products will face temporary supply issues.

Admitting the 'NotPetya' virus had "a very substantial effect on our activities", the company used its Q2 earnings announcement to flag potential supply issues as it admitted its manufacturing facilities were impacted by the attack.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Pharma face-slapped for success
Reputation is finding itself under threat again
Approvals Action
Low dose Symdeko ticked
Along with one generic drug
Special Report
March 2021 PBAC outcomes
Less than a quarter of major new listing requests recommended